All In Biotech

Drug Trial Radar · NCT07575672

Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure

Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure: A Prospective, Multicenter, Randomized, Placebo-Controlled Trial

Last checked: Nov 19, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 2,832 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

2,832

Planned (sponsor's estimate)

Start

Oct 9, 2026

Primary completion

Dec 31, 2029

Study completion Dec 31, 2029

Sponsor

Sponsor type
Academic, hospital or other
First posted
May 8, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a multicenter, double-blind, randomized, placebo-controlled trial. The purpose is to evaluate whether treatment with finerenone in patients with symptomatic severe aortic stenosis undergoing TAVI, and heart failure with LVEF ≥40% is associated with a reduction in the composite endpoint of all-cause mortality or worsening of heart failure. Participants are patients with symptomatic aortic stenosis undergoing TAVI and heart failure with LVEF≥40%. Eligible patients will be randomly assigned in a 1:1 ratio to either the finerenone group or the placebo group. Patients meeting all inclusion criteria and not any exclusion criteria will be invited to participate before discharge. All enrolled patients will consecutively receive treatment, during which serum potassium and estimated glomerular filtration rate will be closely monitored. Follow-up will be conducted at 30 days, 12 months at clinic, and 3 months, 6 months, 9 months and every 6 months after 12 months of enrollment online or via telephone (at clinic if necessary). The final visit will be conducted for all enrolled patients at the end of the study.

Conditions

  • HFpEF - Heart Failure With Preserved Ejection Fraction
  • TAVI(Transcatheter Aortic Valve Implantation)
  • Finerenone

Interventions

  • FinerenoneDrug

    Oral treatment with finerenone daily: * For participants with an eGFR ≤60 mL/min/1.73 m2: Starting dose is 10 mg OD and target dose 20 mg OD. * For participants with an eGFR \>60 mL/min/1.73 m2: Starting dose is 20 mg OD and target dose 40 mg OD.

  • PlaceboDrug

    Oral treatment with placebo daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. A composite of all-cause mortality or worsening of heart failure (hospitalization for HF or urgent HF visit), any of the first occurrence during the follow-up.Time frame: at least 12 months

Locations

61 sites in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Bengbu Medical University

    Bengbu, Anhui, China · Not yet recruiting

  • The First Affiliated Hospital of University of Science and Technology of China

    Hefei, Anhui, China · Not yet recruiting

  • Affiliated Beijing Chaoyang Hospital of Capital Medical University

    Beijing, Beijing Municipality, China · Not yet recruiting

  • Beijing Anzhen Hospital Affiliated to Capital Medical University

    Beijing, Beijing Municipality, China · Not yet recruiting

  • Chinese People's Liberation Army General Hospital

    Beijing, Beijing Municipality, China · Not yet recruiting

  • Fuwai Hospital Chinese Academy of Medical Sciences

    Beijing, Beijing Municipality, China · Not yet recruiting

  • Peking University Third Hospital

    Beijing, Beijing Municipality, China · Not yet recruiting

  • Army Medical Center of the People's Liberation Army

    Chongqing, Chongqing Municipality, China · Not yet recruiting

  • The First Affiliated Hospital of Army Medical University

    Chongqing, Chongqing Municipality, China · Not yet recruiting

  • The Second Affiliated Hospital of Army Medical University

    Chongqing, Chongqing Municipality, China · Not yet recruiting

  • Fujian Medical University Union Hospital

    Fuzhou, Fujian, China · Not yet recruiting

  • Fuzhou University Affiliated Provincial Hospital

    Fuzhou, Fujian, China · Not yet recruiting

  • The First Hospital of Lanzhou University

    Lanzhou, Gansu, China · Not yet recruiting

  • Guangdong Provincial People's Hospital

    Guangzhou, Guangdong, China · Not yet recruiting

  • Nanfang Hospital, Southern Medical University

    Guangzhou, Guangdong, China · Not yet recruiting

  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University

    Guangzhou, Guangdong, China · Not yet recruiting

  • The First Affiliated Hospital, Sun Yat-sen University

    Guangzhou, Guangdong, China · Not yet recruiting

  • Fuwai Huazhong Cardiovascular Hospital

    Zhengzhou, Henan, China · Not yet recruiting

  • Henan Chest Hospital

    Zhengzhou, Henan, China · Not yet recruiting

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China · Not yet recruiting

  • Zhengzhou No.7 People's Hospital

    Zhengzhou, Henan, China · Not yet recruiting

  • Renmin Hospital of Wuhan University

    Wuhan, Hubei, China · Not yet recruiting

  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China · Not yet recruiting

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China · Not yet recruiting

  • Zhongnan Hospital of Wuhan University

    Wuhan, Hubei, China · Not yet recruiting

  • The Second Xiangya Hospital of Central South University

    Changsha, Hunan, China · Not yet recruiting

  • Xiangya Hospital of Central South University

    Changsha, Hunan, China · Not yet recruiting

  • Jiangsu Provincial People's Hospital

    Nanjing, Jiangsu, China · Not yet recruiting

  • Nanjing Drum Tower Hospital

    Nanjing, Jiangsu, China · Not yet recruiting

  • Nanjing First Hospital

    Nanjing, Jiangsu, China · Not yet recruiting

  • Zhongda Hospital Southeast University

    Nanjing, Jiangsu, China · Not yet recruiting

  • Liaoning Provincial People's Hospital

    Shenyang, Liaoning, China · Not yet recruiting

  • People's Liberation Army Northern Theater Command General Hospital

    Shenyang, Liaoning, China · Not yet recruiting

  • The First Hospital of China Medical University

    Shenyang, Liaoning, China · Not yet recruiting

  • The First Affiliated Hospital of Air Force Medical University

    Xi'an, Shaanxi, China · Not yet recruiting

  • The First Affiliated Hospital of Xi'an Jiaotong University

    Xi'an, Shaanxi, China · Not yet recruiting

  • The Second Affiliated Hospital of Air Force Medical University

    Xi'an, Shaanxi, China · Not yet recruiting

  • Qilu Hospital of Shandong University

    Jinan, Shandong, China · Not yet recruiting

  • Shandong Provincial Qianfoshan Hospital

    Jinan, Shandong, China · Not yet recruiting

  • Qingdao Municipal Hospital

    Qingdao, Shandong, China · Not yet recruiting

Showing 40 of 61 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.